{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:24:37Z","timestamp":1793028277742,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T00:00:00Z","timestamp":1364342400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s40263-013-0047-0","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T09:47:48Z","timestamp":1364291268000},"page":"335-343","source":"Crossref","is-referenced-by-count":101,"title":["Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?"],"prefix":"10.1007","volume":"27","author":[{"given":"Katarzyna","family":"Kucharska-Pietura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Mortimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,27]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1037\/0033-2909.121.1.114","volume":"121","author":"DL Penn","year":"1997","unstructured":"Penn DL, Corrigan PW, Bentall RP, et al. Social cognition in schizophrenia. Psychol Bull. 1997;121:114\u201332.","journal-title":"Psychol Bull"},{"key":"47_CR2","volume-title":"Social cognition and schizophrenia","year":"2001","unstructured":"Corrigan PW, Penn DL, editors. Social cognition and schizophrenia. Washington, DC: American Psychological Association; 2001."},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-4388(00)00202-6","volume":"11","author":"R Adolphs","year":"2001","unstructured":"Adolphs R. The neurobiology of social cognition. Curr Opin Neurobiol. 2001;11:231\u20139.","journal-title":"Curr Opin Neurobiol"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.schres.2005.12.856","volume":"83","author":"N Bigelow","year":"2006","unstructured":"Bigelow N, Paardiso S, Adolphs R, et al. Perception of social stimuli in schizophrenia. Schizophr Res. 2006;83:257\u201367.","journal-title":"Schizophr Res"},{"issue":"Suppl 1","key":"47_CR5","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/schbul\/sbl029","volume":"32","author":"SM Couture","year":"2006","unstructured":"Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull. 2006;32(Suppl 1):S44\u201363.","journal-title":"Schizophr Bull"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psychres.2004.10.007","volume":"133","author":"M Br\u00fcne","year":"2005","unstructured":"Br\u00fcne M. Emotion recognition, \u2018theory of mind\u2019, and social behaviour in schizophrenia. Psychiatry Res. 2005;133:135\u201347.","journal-title":"Psychiatry Res"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eurpsy.2010.10.002","volume":"27","author":"M Br\u00fcne","year":"2012","unstructured":"Br\u00fcne M, Schaub D. Mental state attribution in schizophrenia: what distinguishes patients with \u201cpoor\u201d from patients with \u201cfair\u201d mentalising skills? Eur Psychiatry. 2012;27:358\u201364.","journal-title":"Eur Psychiatry"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.yhbeh.2011.12.014","volume":"61","author":"RP Ebstein","year":"2012","unstructured":"Ebstein RP, Knafo A, Mankuta D, et al. The contributions of oxytocin and vasopressin pathway genes to human behavior. Horm Behav. 2012;61:359\u201379.","journal-title":"Horm Behav"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.biopsych.2007.03.025","volume":"62","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Gl\u00e4scher J, et al. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry. 2007;62:1187\u201390.","journal-title":"Biol Psychiatry"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biopsych.2006.07.015","volume":"61","author":"G Domes","year":"2007","unstructured":"Domes G, Heinrichs M, Michel A, et al. Oxytocin improves \u201cmind-reading\u201d in humans. Biol Psychiatry. 2007;61:31\u20133.","journal-title":"Biol Psychiatry"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2011.07.027","volume":"132","author":"CA Pedersen","year":"2011","unstructured":"Pedersen CA, Gibson CM, Rau SW, et al. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res. 2011;132:50\u20133.","journal-title":"Schizophr Res"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/schbul\/sbq015","volume":"37","author":"AJ Rosenfeld","year":"2011","unstructured":"Rosenfeld AJ, Lieberman JA, Jarskog LF. Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophr Bull. 2011;37:1077\u201387.","journal-title":"Schizophr Bull"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","volume":"76","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Ishii H, Bonaccorso S, et al. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem. 2001;76:1521\u201331.","journal-title":"J Neurochem"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","volume":"52","author":"S Kapur","year":"2001","unstructured":"Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med. 2001;52:503\u201317.","journal-title":"Annu Rev Med"},{"key":"47_CR15","first-page":"295","volume":"4","author":"S Akhondzadeh","year":"2001","unstructured":"Akhondzadeh S. The 5-HT hypothesis of schizophrenia. IDrugs. 2001;4:295\u2013300.","journal-title":"IDrugs"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","volume":"160","author":"S Kapur","year":"2003","unstructured":"Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13\u201323.","journal-title":"Am J Psychiatry"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.wnf.0000185824.57690.f0","volume":"28","author":"P Salgado-Pineda","year":"2005","unstructured":"Salgado-Pineda P, Delaveau P, Blin O, et al. Dopaminergic contribution to the regulation of emotional perception. Clin Neuropharmacol. 2005;28:228\u201337.","journal-title":"Clin Neuropharmacol"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2007.07.004","volume":"99","author":"J Addington","year":"2008","unstructured":"Addington J, Addington D. Social and cognitive functioning in psychosis. Schizophr Res. 2008;99:176\u201381.","journal-title":"Schizophr Res"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1192\/bjp.187.6.523","volume":"187","author":"K Kucharska-Pietura","year":"2005","unstructured":"Kucharska-Pietura K, David AS, Masiak M, et al. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br J Psychiatry. 2005;187:523\u20138.","journal-title":"Br J Psychiatry"},{"key":"47_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.107.035899","volume":"191","author":"M Sprong","year":"2007","unstructured":"Sprong M, Schothorst P, Vos E, et al. Theory of mind in schizophrenia: meta-analysis. Br J Psychiatry. 2007;191:5\u201313.","journal-title":"Br J Psychiatry"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291706009342","volume":"37","author":"R Mizrahi","year":"2007","unstructured":"Mizrahi R, Korostil M, Starkstein SE, et al. The effect of antipsychotic treatment on Theory of Mind. Psychol Med. 2007;37:595\u2013601.","journal-title":"Psychol Med"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000067062","volume":"35","author":"R Roncone","year":"2002","unstructured":"Roncone R, Falloon IR, Mazza M, et al. Is theory of mind in schizophrenia more strongly associated with clinical and social functioning than with neurocognitive deficits? Psychopathology. 2002;35:280\u20138.","journal-title":"Psychopathology"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02190342","volume":"242","author":"W Gaebel","year":"1992","unstructured":"Gaebel W, W\u00f6lwer W. Facial expression and emotional face recognition in schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 1992;242:46\u201352.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0920-9964(00)00099-2","volume":"48","author":"J Edwards","year":"2001","unstructured":"Edwards J, Pattison PE, Jackson HJ, et al. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr Res. 2001;48:235\u201353.","journal-title":"Schizophr Res"},{"key":"47_CR25","first-page":"58","volume":"8","author":"F Tr\u00e9meau","year":"2006","unstructured":"Tr\u00e9meau F. Emotion deficits in schizophrenia. Dial Clin Neurosci. 2006;8:58\u201368.","journal-title":"Dial Clin Neurosci"},{"key":"47_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-1781(02)00004-5","volume":"109","author":"DL Penn","year":"2002","unstructured":"Penn DL, Ritchie M, Francis J, et al. Social perception in schizophrenia: the role of context. Psychiatry Res. 2002;109:149\u201359.","journal-title":"Psychiatry Res"},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","volume":"56","author":"MF Green","year":"2004","unstructured":"Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301\u20137.","journal-title":"Biol Psychiatry"},{"key":"47_CR28","volume-title":"Affektivit\u00e4t, Suggestibilit\u00e4t","author":"EP Bleuler","year":"1906","unstructured":"Bleuler EP. Affektivit\u00e4t, Suggestibilit\u00e4t. Halle: Paranoi; 1906."},{"key":"47_CR29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1176\/appi.ajp.163.11.1918","volume":"163","author":"PD Harvey","year":"2006","unstructured":"Harvey PD, Patterson TL, Potter LS, et al. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning. Am J Psychiatry. 2006;163:1918\u201325.","journal-title":"Am J Psychiatry"},{"key":"47_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2008.07.025","volume":"178","author":"RJ Hempel","year":"2010","unstructured":"Hempel RJ, Dekker JA, Van Beveren NJ, et al. The effect of antipsychotic medication on facial affect recognition in schizophrenia: a review. Psychiatry Res. 2010;178:1\u20139.","journal-title":"Psychiatry Res"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1176\/appi.ajp.162.9.1746","volume":"162","author":"ES Herbener","year":"2005","unstructured":"Herbener ES, Hill K, Marvin RW, et al. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia. Am J Psychiatry. 2005;162:1746\u20138.","journal-title":"Am J Psychiatry"},{"key":"47_CR32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0920-9964(98)00026-7","volume":"31","author":"KS Kee","year":"1998","unstructured":"Kee KS, Kern RS, Marshall BD, et al. Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings. Schizophr Res. 1998;31:159\u201365.","journal-title":"Schizophr Res"},{"key":"47_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2009.08.016","volume":"115","author":"DL Penn","year":"2009","unstructured":"Penn DL, Keefe RS, Davis SM, et al. The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. Schizophr Res. 2009;115:17\u201323.","journal-title":"Schizophr Res"},{"key":"47_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-3956(94)00033-N","volume":"29","author":"SF Lewis","year":"1995","unstructured":"Lewis SF, Garver DL. Treatment and diagnostic subtype in facial recognition in schizophrenia. J Psychiatry Res. 1995;29:5\u201311.","journal-title":"J Psychiatry Res"},{"key":"47_CR35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3371\/CSRP.6.1.2","volume":"6","author":"K Kucharska-Pietura","year":"2012","unstructured":"Kucharska-Pietura K, Mortimer A, Tylec A, et al. Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs. Clin Schizophr Relat Psychoses. 2012;6:14\u201320.","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"47_CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-1781(03)00166-5","volume":"120","author":"LM Williams","year":"2003","unstructured":"Williams LM, Loughland CM, Green MJ, et al. Emotion perception in schizophrenia: an eye movement study comparing the effectiveness of risperidone vs. haloperidol. Psychiatry Res. 2003;120:13\u201327.","journal-title":"Psychiatry Res"},{"key":"47_CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0010-440X(94)90016-7","volume":"35","author":"JS Brekke","year":"1994","unstructured":"Brekke JS, DeBonis JA, Graham JW. A latent structure analysis of the positive and negative symptoms in schizophrenia. Compr Psychiatry. 1994;35:252\u20139.","journal-title":"Compr Psychiatry"},{"key":"47_CR38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.psychres.2010.04.006","volume":"178","author":"DL Roberts","year":"2010","unstructured":"Roberts DL, Penn DL, Corrigan P, et al. Antipsychotic medication and social cue recognition in chronic schizophrenia. Psychiatry Res. 2010;178:46\u201350.","journal-title":"Psychiatry Res"},{"key":"47_CR39","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/schbul\/sbm145","volume":"34","author":"MF Green","year":"2008","unstructured":"Green MF, Penn DL, Bentall R, et al. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008;34:1211\u201320.","journal-title":"Schizophr Bull"},{"key":"47_CR40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/13546800902732970","volume":"14","author":"DR Combs","year":"2009","unstructured":"Combs DR, Penn DL, Michael CO, et al. Perceptions of hostility by persons with and without persecutory delusions. Cogn Neuropsychiatry. 2009;14:30\u201352.","journal-title":"Cogn Neuropsychiatry"},{"key":"47_CR41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/appi.ajp.161.2.364","volume":"161","author":"AS Bellack","year":"2004","unstructured":"Bellack AS, Schooler NR, Marder SR, et al. Do clozapine and risperidone affect social competence and problem solving? Am J Psychiatry. 2004;161:364\u20137.","journal-title":"Am J Psychiatry"},{"key":"47_CR42","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2007.06091515","volume":"164","author":"MJ Sergi","year":"2007","unstructured":"Sergi MJ, Green MF, Widmark C, et al. Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol. Am J Psychiatry. 2007;164:1585\u201392.","journal-title":"Am J Psychiatry"},{"key":"47_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.schres.2008.09.012","volume":"106","author":"JP Machado de Sousa","year":"2008","unstructured":"Machado de Sousa JP, Hallak JE. Neurocognitive functioning and facial affect recognition in treatment-resistant schizophrenia treated with clozapine. Schizophr Res. 2008;106:371\u20132.","journal-title":"Schizophr Res"},{"key":"47_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0920-9964(03)00185-3","volume":"66","author":"KH Littrell","year":"2004","unstructured":"Littrell KH, Petty RG, Hilligoss NM, et al. Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine. Schizophr Res. 2004;66:201\u20132.","journal-title":"Schizophr Res"},{"key":"47_CR45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2007.04.010","volume":"94","author":"I Savina","year":"2007","unstructured":"Savina I, Beninger RJ. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications. Schizophr Res. 2007;94:128\u201338.","journal-title":"Schizophr Res"},{"key":"47_CR46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/15622970701432536","volume":"10","author":"E Fakra","year":"2009","unstructured":"Fakra E, Salgado-Pineda P, Besnier N, et al. Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study. World J Biol Psychiatry. 2009;10:719\u201328.","journal-title":"World J Biol Psychiatry"},{"key":"47_CR47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s002130100760","volume":"156","author":"CA Heidbreder","year":"2001","unstructured":"Heidbreder CA, Foxton R, Cilia J, et al. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacol Berl. 2001;156:338\u201351.","journal-title":"Psychopharmacol Berl"},{"issue":"Suppl 2","key":"47_CR48","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S0013-7006(11)70041-0","volume":"37","author":"E Fakra","year":"2011","unstructured":"Fakra E, Kaladjian A, Adida M, et al. Schizophrenia, psychotropic drugs and cognition. Encephale. 2011;37(Suppl 2):S137\u201342.","journal-title":"Encephale"},{"key":"47_CR49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1037\/0021-843X.102.2.312","volume":"102","author":"SL Kerr","year":"1993","unstructured":"Kerr SL, Neale JM. Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance? J Abnorm Psychol. 1993;102:312\u20138.","journal-title":"J Abnorm Psychol"},{"key":"47_CR50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2012.03.005","volume":"138","author":"G Sachs","year":"2012","unstructured":"Sachs G, Winklbaur B, Jagsch R, et al. Training of affect recognition (TAR) in schizophrenia\u2013impact on functional outcome. Schizophr Res. 2012;138:262\u20137.","journal-title":"Schizophr Res"},{"key":"47_CR51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2006.12.010","volume":"91","author":"DR Combs","year":"2007","unstructured":"Combs DR, Adams SD, Penn DL, et al. Social cognition and interaction training (SCIT) for inpatients with schizophrenia spectrum disorders: preliminary findings. Schizophr Res. 2007;91:112\u20136.","journal-title":"Schizophr Res"},{"key":"47_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2008.02.007","volume":"166","author":"DL Roberts","year":"2009","unstructured":"Roberts DL, Penn DL. Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Res. 2009;166:141\u20137.","journal-title":"Psychiatry Res"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-013-0047-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0047-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T13:12:21Z","timestamp":1551186741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-013-0047-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,27]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s40263-013-0047-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,27]]}}}